PUBLIC ASSESSMENT REPORT of the Medicines Evaluation Board in the Netherlands Budenofalk Schuim 2 mg, rectal foam Dr. Falk Pharm
![PDF) Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis, a Randomised, Controlled, Non-inferiority Trial PDF) Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis, a Randomised, Controlled, Non-inferiority Trial](https://i1.rgstatic.net/publication/361356154_Novel_Budesonide_Suppository_and_Standard_Budesonide_Rectal_Foam_Induce_High_Rates_of_Clinical_Remission_and_Mucosal_Healing_in_Active_Ulcerative_Proctitis_a_Randomised_Controlled_Non-inferiority_Tria/links/6362548a431b1f5300646d6b/largepreview.png)
PDF) Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis, a Randomised, Controlled, Non-inferiority Trial
![Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis | Digestive Diseases and Sciences Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis | Digestive Diseases and Sciences](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10620-015-3868-5/MediaObjects/10620_2015_3868_Fig1_HTML.gif)